ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,250Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 298

$510K Total Retail Price of All Prescriptions

Rank: 28 out of 298

465 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 592 500 1 1
SIMVASTATIN 592 462 1 2
LISINOPRIL 563 465 3 4
OMEPRAZOLE 540 445 4 3
AMLODIPINE BESYLATE 515 472 5 6
METOPROLOL TARTRATE 435 358 6 9
METFORMIN HCL 338 303 7 10
WARFARIN SODIUM 326 301 8 7
FUROSEMIDE 313 286 9 5
HYDROCHLOROTHIAZIDE 290 269 10 13
METOPROLOL SUCCINATE 279 262 11 12
TRAMADOL HCL 218 160 12 15
SERTRALINE HCL 212 180 13 19
ATORVASTATIN CALCIUM 196 184 14 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 147 15 30
GABAPENTIN 179 159 16 20
CITALOPRAM HBR 161 116 17 17
NAMENDA 155 132 18 35
ATENOLOL 151 139 19 16
CRESTOR 127 124 20 26
DONEPEZIL HCL 126 114 21 22
POTASSIUM CHLORIDE 122 122 22 11
ZOLPIDEM TARTRATE 121 109 23 25
BENAZEPRIL HCL 119 119 24 52
CLOPIDOGREL 119 107 24 36
LOSARTAN POTASSIUM 112 88 26 18
DIOVAN 107 107 27 47
IPRATROPIUM BROMIDE 105 91 28 107
ALBUTEROL SULFATE 103 100 29 75
RANITIDINE HCL 98 65 30 59
MIRTAZAPINE 95 94 31 37
DIGOXIN 91 81 32 27
ALLOPURINOL 89 83 33 28
ZETIA 85 85 34 83
POLYETHYLENE GLYCOL 3350 80 56 35 29
TAMSULOSIN HCL 79 59 36 24
NEXIUM 76 64 37 40
ISOSORBIDE MONONITRATE ER 71 59 38 45
PLAVIX 70 70 39 70
PREDNISONE 66 57 40 33
SYNTHROID 66 51 40 42
GLIPIZIDE XL 65 60 42 92
NABUMETONE 60 48 43 127
ADVAIR DISKUS 59 52 44 46
CEPHALEXIN 58 40 45 94
PANTOPRAZOLE SODIUM 57 36 46 110
GLIPIZIDE 53 42 47 69
GLIPIZIDE-METFORMIN 53 53 47 231
FLUTICASONE PROPIONATE 53 43 47 38
SUMATRIPTAN SUCCINATE 50 0 50 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.